Main menu

NEW YORK (GenomeWeb News) – Nanogen disclosed in a regulatory filing with the US Securities and Exchange Commission today that it will restate its net loss for the first quarter of 2008 due to an accounting error.

As a result of the restatement, Nanogen’s net loss for the quarter ended March 31 will be $26.4 million rather than the $23 million it previously recorded.